LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H (HK:2291) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
LEPU ScienTech Medical Technology, a notable Chinese medical technology firm, has announced changes to its board of directors and committee roles effective December 9, 2024. The company outlined the new structure of its executive, non-executive, and independent non-executive directors, as well as their respective positions in the audit, remuneration, and nomination committees. These changes are expected to steer the company’s strategic direction and governance.
For further insights into HK:2291 stock, check out TipRanks’ Stock Analysis page.